Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Renal Failure|March 5, 2010
Reduced expression of perlecan in the aorta of secondary hyperparathyroidism model rats with medial calcificationMaki Shibata, Takashi Shigematsu, Ikuji Hatamura, et al.
Journal of the American Society of Nephrology : JASN|December 3, 2004
Biochemical and cellular effects of direct maxacalcitol injection into parathyroid gland in uremic ratsKazuhiro Shiizaki, Shigeo Negi, Ikuji Hatamura, et al.
Journal of the American Society of Nephrology : JASN|October 7, 2004
Calcimimetic compound upregulates decreased calcium-sensing receptor expression level in parathyroid glands of rats with chronic renal insufficiencyMasahide Mizobuchi, Ikuji Hatamura, Hiroaki Ogata, et al.
International Journal of Nephrology and Renovascular Disease|June 23, 2012
The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patientsTakashi Shigematsu, Yuri Nakashima, Masaki Ohya, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
Significance of serum magnesium as an independent correlative factor on the parathyroid hormone level in uremic patientsMasaki Ohya, Shigeo Negi, Toshifumi Sakaguchi, et al.
Journal of Inflammation (London, England)|May 16, 2012
Effect of erythropoietin-stimulating agent on uremic inflammationYuri Tanaka, Nobuhiko Joki, Hiroki Hase, et al.
Clinical and Experimental Nephrology|September 14, 2011
Influence of renin-angiotensin system on serum parathyroid hormone levels in uremic patientsFumihiko Koiwa, Daisuke Komukai, Makoto Hirose, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 22, 2015
Possible prevention of dialysis-requiring congestive heart failure by angiotensin-II receptor blockers in non-dialysis Japanese patients with Stage 5 chronic kidney diseaseMasato Ikeda, Masatsugu Nakao, Keita Hirano, et al.
Pageof 4